These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Impact of anxiety, stress and depression related to COVID-19 pandemic on the course of hereditary angioedema with C1-inhibitor deficiency. Eyice Karabacak D; Demir S; Yeğit OO; Can A; Terzioğlu K; Ünal D; Olgaç M; Coşkun R; Çolakoğlu B; Büyüköztürk S; Gelincik A Allergy; 2021 Aug; 76(8):2535-2543. PubMed ID: 33650198 [TBL] [Abstract][Full Text] [Related]
4. Effect of COVID-19 on hereditary angioedema activity and quality of life. Can Bostan O; Tuncay G; Damadoglu E; Karakaya G; Kalyoncu AF Allergy Asthma Proc; 2021 Sep; 42(5):403-408. PubMed ID: 34474710 [No Abstract] [Full Text] [Related]
5. HAE patient self-sampling for biomarker establishment. Förster TM; Magerl M; Maurer M; Zülbahar S; Zielke S; Inhaber N; Crocetta D; Rolfs A; Skrahina V Orphanet J Rare Dis; 2021 Sep; 16(1):399. PubMed ID: 34583739 [TBL] [Abstract][Full Text] [Related]
6. The relationship between anxiety and quality of life in children with hereditary angioedema. Kessel A; Farkas H; Kivity S; Veszeli N; Kőhalmi KV; Engel-Yeger B Pediatr Allergy Immunol; 2017 Nov; 28(7):692-698. PubMed ID: 28692169 [TBL] [Abstract][Full Text] [Related]
7. Emotional processes and stress in children affected by hereditary angioedema with C1-inhibitor deficiency: a multicenter, prospective study. Savarese L; Bova M; De Falco R; Guarino MD; De Luca Picione R; Petraroli A; Senter R; Traverso C; Zabotto M; Zanichelli A; Zito E; Alessio M; Cancian M; Cicardi M; Franzese A; Perricone R; Marone G; Valerio P; Freda MF Orphanet J Rare Dis; 2018 Jul; 13(1):115. PubMed ID: 30005674 [TBL] [Abstract][Full Text] [Related]
8. Psychological processes in the experience of hereditary angioedema in adult patients: an observational study. Savarese L; Bova M; Maiello A; Petraroli A; Mormile I; Cancian M; Senter R; Zanichelli A; Spadaro G; Freda MF Orphanet J Rare Dis; 2021 Jan; 16(1):23. PubMed ID: 33422102 [TBL] [Abstract][Full Text] [Related]
9. Global perceptions of the current and future impacts of COVID-19 on hereditary angioedema management. Grivcheva-Panovska V; Craig TJ; Longhurst H; Bara N; Panovska I Allergy Asthma Proc; 2022 Jan; 43(1):e1-e10. PubMed ID: 34983717 [No Abstract] [Full Text] [Related]
10. Patient-reported burden of hereditary angioedema: findings from a patient survey in the United States. Banerji A; Davis KH; Brown TM; Hollis K; Hunter SM; Long J; Jain G; Devercelli G Ann Allergy Asthma Immunol; 2020 Jun; 124(6):600-607. PubMed ID: 32169514 [TBL] [Abstract][Full Text] [Related]
11. The importance of recognizing and managing a rare form of angioedema: hereditary angioedema due to C1-inhibitor deficiency. Jacobs J; Neeno T Postgrad Med; 2021 Aug; 133(6):639-650. PubMed ID: 33993830 [TBL] [Abstract][Full Text] [Related]
12. Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema. Lumry WR; Craig T; Zuraw B; Longhurst H; Baker J; Li HH; Bernstein JA; Anderson J; Riedl MA; Manning ME; Keith PK; Levy DS; Caballero T; Banerji A; Gower RG; Farkas H; Lawo JP; Pragst I; Machnig T; Watson DJ J Allergy Clin Immunol Pract; 2018; 6(5):1733-1741.e3. PubMed ID: 29391286 [TBL] [Abstract][Full Text] [Related]
13. Health-related quality of life among children with hereditary angioedema. Engel-Yeger B; Farkas H; Kivity S; Veszeli N; Kőhalmi KV; Kessel A Pediatr Allergy Immunol; 2017 Jun; 28(4):370-376. PubMed ID: 28258590 [TBL] [Abstract][Full Text] [Related]
15. Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study. Lumry WR; Zuraw B; Cicardi M; Craig T; Anderson J; Banerji A; Bernstein JA; Caballero T; Farkas H; Gower RG; Keith PK; Levy DS; Li HH; Magerl M; Manning M; Riedl MA; Lawo JP; Prusty S; Machnig T; Longhurst H; Orphanet J Rare Dis; 2021 Feb; 16(1):86. PubMed ID: 33588897 [TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life in Danish children with hereditary angioedema. Aabom A; Nguyen D; Fisker N; Bygum A Allergy Asthma Proc; 2017 Nov; 38(6):440-446. PubMed ID: 29046193 [TBL] [Abstract][Full Text] [Related]
17. The symptom experience of hereditary angioedema (HAE) patients beyond HAE attacks: literature review and clinician interviews. Jean-Baptiste M; Itzler R; Prusty S; Supina D; Martin ML Orphanet J Rare Dis; 2022 Jun; 17(1):232. PubMed ID: 35710442 [TBL] [Abstract][Full Text] [Related]
18. Hereditary angioedema in Greece: the first results of the greek hereditary angioedema registry. Psarros F; Koutsostathis N; Farmaki E; Speletas MG; Germenis AE Int Arch Allergy Immunol; 2014; 164(4):326-32. PubMed ID: 25277223 [TBL] [Abstract][Full Text] [Related]
19. Novel Vasoregulatory Aspects of Hereditary Angioedema: the Role of Arginine Vasopressin, Adrenomedullin and Endothelin-1. Kajdácsi E; Jani PK; Csuka D; Varga L; Prohászka Z; Farkas H; Cervenak L J Clin Immunol; 2016 Feb; 36(2):160-70. PubMed ID: 26873707 [TBL] [Abstract][Full Text] [Related]
20. High-molecular-weight kininogen cleavage correlates with disease states in the bradykinin-mediated angioedema due to hereditary C1-inhibitor deficiency. Suffritti C; Zanichelli A; Maggioni L; Bonanni E; Cugno M; Cicardi M Clin Exp Allergy; 2014 Dec; 44(12):1503-14. PubMed ID: 24552232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]